MediThinQ, a South Korean leader in wearable extended reality (XR) surgical displays, has entered a strategic partnership with Sinopharm, China’s largest pharmaceutical and medical distribution company. This exclusive distribution agreement grants Sinopharm the rights to bring MediThinQ’s flagship product, Scopeye, to hospitals across China. The collaboration leverages Sinopharm’s vast healthcare network and established presence in Chinese medical markets, enabling rapid deployment of Scopeye in major surgical centers nationwide. The partnership was formalized in a signing ceremony underscoring both companies’ commitment to advancing surgical innovation in one of the world’s largest healthcare systems.

The partnership between MediThinQ and Sinopharm is critical not only for market access but also for accelerating the adoption of wearable surgical technology in China’s fast-evolving healthcare landscape. Sinopharm’s extensive distribution capabilities and trusted relationships with top-tier hospitals provide MediThinQ with a powerful platform to introduce cutting-edge XR visualization tools. This alignment supports China’s national push toward digital healthcare transformation and smart operating rooms, making it possible to improve surgical outcomes and efficiency at scale across the country.

MediThinQ’s Scopeye headset is a breakthrough innovation that delivers real-time, high-definition imaging directly into surgeons’ line of sight, streamlining complex procedures by eliminating the need to look away from the surgical field. This wireless, ergonomically designed XR system enhances focus, precision, and intraoperative workflow. The technology has received regulatory approval in multiple regions and has been validated through over 10,000 clinical tests globally. With Sinopharm’s support, Scopeye is poised to revolutionize surgical visualization in China, marking a significant step in MediThinQ’s global expansion and the broader adoption of immersive technologies in modern medicine.

MedTech Spectrum's Summary

Strategic Partnership: MediThinQ and Sinopharm have formed an exclusive distribution agreement, leveraging Sinopharm’s vast network to introduce MediThinQ’s wearable XR surgical displays, Scopeye, across major hospitals in China.

Innovative Technology: Scopeye is the world’s first extended reality headset designed for live surgery, delivering real-time, high-definition imaging directly to surgeons’ line of sight to enhance precision, ergonomics, and workflow.

Market Importance: This partnership accelerates the adoption of advanced surgical visualization in China’s rapidly evolving healthcare system, supporting digital transformation and improving surgical outcomes at scale.